| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 37.811 | 39.472 | 55.921 | - | - | - | - | - | - | - |
| Total Income - EUR | 37.811 | 39.472 | 55.921 | - | - | - | - | - | - | - |
| Total Expenses - EUR | 22.644 | 18.351 | 25.528 | - | - | - | - | - | - | - |
| Gross Profit/Loss - EUR | 15.166 | 21.122 | 30.393 | - | - | - | - | - | - | - |
| Net Profit/Loss - EUR | 14.032 | 20.332 | 29.834 | - | - | - | - | - | - | - |
| Employees | 3 | 3 | 3 | - | - | - | - | - | - | - |
Check the financial reports for the company - Toximed Grup S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 935 | 302 | 834 | - | - | - | - | - | - | - |
| Current Assets | 85.597 | 22.507 | 51.366 | - | - | - | - | - | - | - |
| Inventories | 0 | 0 | 0 | - | - | - | - | - | - | - |
| Receivables | 78.226 | 17.609 | 48.491 | - | - | - | - | - | - | - |
| Cash | 7.371 | 4.898 | 2.875 | - | - | - | - | - | - | - |
| Shareholders Funds | 84.186 | 20.493 | 49.979 | - | - | - | - | - | - | - |
| Social Capital | 135 | 134 | 131 | - | - | - | - | - | - | - |
| Debts | 2.346 | 2.327 | 2.245 | - | - | - | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | - | - | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Toximed Grup S.r.l.